R332 (Pantoprazole sodium delayed release 20 mg)
Pill imprint R332 has been identified as Pantoprazole sodium delayed release 20 mg.
Pantoprazole is used in the treatment of gerd; barrett's esophagus; zollinger-ellison syndrome; helicobacter pylori infection; erosive esophagitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for R332 (Pantoprazole sodium delayed release 20 mg)
- 20 mg
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol 400
ferric oxide yellow
More about pantoprazole
- Pantoprazole delayed-release tablets
- Pantoprazole suspension
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...